FDA OKs Iqirvo, First-in-Class PPAR Treatment for PBC
The US Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo (elafibranor; Ipsen) for treatment of primary biliary ...
Read moreDetailsThe US Food and Drug Administration (FDA) has granted accelerated approval for Iqirvo (elafibranor; Ipsen) for treatment of primary biliary ...
Read moreDetailsGepotidacin, an investigational antibiotic, proved noninferior to dual therapy for the treatment of uncomplicated urogenital gonorrhea, according to results of ...
Read moreDetailsAEF0117, a first-in-class drug, has shown potential in treating cannabis use disorder (CUD) by inhibiting specific signals in cannabinoid receptors. ...
Read moreDetailsM | T | W | T | F | S | S |
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
7 | 8 | 9 | 10 | 11 | 12 | 13 |
14 | 15 | 16 | 17 | 18 | 19 | 20 |
21 | 22 | 23 | 24 | 25 | 26 | 27 |
28 | 29 | 30 |
© 2023 earth-news.info
© 2023 earth-news.info